布告栏

Adalimumab may be effective treatment for juvenile rheumatoid arthritis, report suggests

• 抽象的

临床试验报告

Zoledronic acid in the management of osteoporosis: the HORIZON trials

E Michael Lewiecki

• 抽象的

药物评价

Desloratadine: a review of pharmacology and clinical efficacy in allergic rhinitis and urticaria

Evrim Alyamac Dizdar, Bulent Enis Sekerel and Ayfer Tuncer

• 抽象的

药物评价

Ranolazine extended-release for chronic angina

Laura M Gruen and Carl J Pepine

• 抽象的

社论

The search for new anticoagulants: dabigatran etexilate

Aurangzeb Siddique, Eduard Shantsila and Gregory YH Lip

• 抽象的

附录

Author guidelines: Volume 5 Issue 6

• 抽象的

附录

Acknowledgement: Volume 5 Issue 6

• 抽象的

附录

Compound Index: Volume 5 Issue 6

• 抽象的

附录

Author index: Volume 5 Issue 6

• 抽象的

附录

Glossary: Volume 5 Issue 6

• 抽象的

特别报告

Secondary hypertension: etiology and mechanism of disease

Jeffrey H Freihage, Aravinda Nanjundappa and Robert S Dieter

• 抽象的

评论文章

Weight-reducing drug therapy and hypertension

Julia Schimkus and Jurgen Scholze

• 抽象的

评论文章

Continuing evolution of the role of β-blockers in the treatment of hypertension

Thomas D Giles

• 抽象的

评论文章

Hypertension in practice: towards the year 2010

D Gareth Beevers

• 抽象的

药物评价

Clevidipine and the management of acute hypertension

Joseph Varon and Jorge E Angeles

• 抽象的

药物评价

Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension

Robert Weiss, Christopher A Graybill, Jennifer Linseman & Marshelle Warren

• 抽象的

面试

Web-based care: a new paradigm in hypertension management?

Beverly Green

• 抽象的

前言

Looking backwards and moving forwards in the therapy of hypertension

Robert J MacFadyen

• 抽象的